Sort
39,280 grants matching “leukemia”
REGULATION OF HEMATOPOIETIC PROGENITORS BY DE NOVO DNA METHYLATION
$664,850Margaret Goodell · Baylor College Of Medicine · R01 · FY2021 · DK
Phase 2 clinical trial of a novel T cell therapy following bridging therapy with hypomethylating agents for relapsed AML patients post-stem cell transplant
$664,838Juan Fernando Vera · Marker Therapeutics, Inc. · R44 · FY2024 · CA
Phase 2 clinical trial of a novel T cell therapy following bridging therapy with hypomethylating agents for relapsed AML patients post-stem cell transplant
$664,838Juan Fernando Vera · Marker Therapeutics, Inc. · R44 · FY2025 · CA
Phase 2 clinical trial of a novel T cell therapy following bridging therapy with hypomethylating agents for relapsed AML patients post-stem cell transplant
$664,838Juan Fernando Vera · Marker Therapeutics, Inc. · R44 · FY2023 · CA
Vascular Toxicity of Benzene
$664,616Sanjay Srivastava · University Of Louisville · R01 · FY2024 · ES
Vascular Toxicity of Benzene
$664,616Sanjay Srivastava · University Of Louisville · R01 · FY2025 · ES
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
$664,612Brian D Gonzalez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Hydrogel Particle-Based microRNA Profiling for Discovery and Cancer Diagnostics
$664,407Daniel Pregibon · Firefly Bioworks, Inc. · R44 · FY2012 · CA
Developing Mathmatical Framework to Uncover the Sequence of Genetic Events During
$664,221Franziska Michor · Dana-Farber Cancer Inst · U54 · FY2012 · CA
BAFF-R CAR T cell therapy for ALL
$664,070Larry W Kwak · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Motor Proficiency and Physical Activity in Adult Survivors of Childhood ALL
$664,060Kirsten Kimberlie Ness · St. Jude Children'S Research Hospital · R01 · FY2010 · CA
Using mouse models to probe the relationship of oncogenesis to development and o
$664,043Eric C Holland · Fred Hutchinson Cancer Research Center · U01 · FY2013 · CA
Immunobiology of Normal and Neoplastic Lymphocytes
$663,998Warren S Pear · University Of Pennsylvania · T32 · FY2020 · CA
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
$663,995Leonard Neckers · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Nutrient Regulation of Cancer Cell Growth
$663,928Heather Christofk · University Of California Los Angeles · R01 · FY2023 · CA
Therapeutic targeting of RNA splicing catalysis through inhibition of Protein Arginine Methylation
$663,748Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Project 2: Regulation of Pre-mRNA Splicing in Tumorigenesis
$663,644Adrian R Krainer · Cold Spring Harbor Laboratory · P01 · FY2021 · CA
Project 2: Regulation of Pre-mRNA Splicing in Tumorigenesis
$663,644Adrian R Krainer · Cold Spring Harbor Laboratory · P01 · FY2020 · CA
Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women
$663,406Joan M Lappe · Creighton University · R01 · FY2013 · CA
Third-party âoff the shelfâ mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT
$663,330Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · R01 · FY2022 · HL
Third-party âoff the shelfâ mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT
$663,330Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · R01 · FY2020 · HL
Third-party âoff the shelfâ mature or precursor CAR T cells to prevent or treat malignant relapse after allo HCT
$663,330Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · R01 · FY2021 · HL
Genomic Approaches to Aneuploidy
$663,302Roger H Reeves · Johns Hopkins University · R01 · FY2010 · HD
ITSC for Leukemia: Novel Molecular strategies for NCTN "Individualized" Therapies
$663,301John C Byrd · University Of Cincinnati · UG1 · FY2023 · CA
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
$663,194Donald F Hunt · University Of Virginia · R37 · FY2007 · AI